US: +1 646-781-8004 | Europe:+44-203-868-8738 | APAC:+91-744-778-0008

Research Antibodies And Reagents Market

Release date:

Feb-2020

Region:

global

Research Code:MRHC - 104356

Sku:MRHC - 104356

Research Antibodies and Reagents Market by Product {Antibodies [Type (Primary, Secondary), Production, Source, Research Area (Oncology, Neurology)], Reagents}, Technology (ELISA, Western Blot), Application, End User (Pharma, Academia) - Global Forecast to 2027

  • Report ID: MRHC - 104356
  • Pages: 272
  • Feb-2020
  • Formats*: PDF
  • Category: Healthcare
  • Delivery: 2 to 4 Hours
COVID-19

This report provides pre & post COVID-19 market estimates.

The research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to 2027 to reach USD 6.32 billion by 2027. The main route of causing various chronic diseases is the presence of specific proteins, namely antigens, on the surface of pathogenic organisms. The immune system plays an important role in fighting against these antigens by producing three protein types-complement protein, antibodies, and interferons. Antibodies are formed by plasma or B or T cells in the body.

Moreover, they have high specificity, strong affinity, and long-term memory against specific pathogens. Thus, these antibodies are used for various applications. The factors such as increasing proteomics and genomics research studies, increased funding for research activities, and growing industry-academia collaborations drive the growth of this market.

However, high cost and time related to identifying and developing potential antibodies are expected to restrict this market's growth to a certain extent.

Research Antibodies and Reagents Market

                                                        Click here to: Get Free Sample Pages of this Report

Impact of COVID-19 on Research Antibodies and Reagents Market

The increasing cases of COVID-19 have led to a robust increase in research-based activities to develop effective diagnosis or therapy. The growing number of research activities is driving the adoption of research antibodies and reagents by various end-users. Some of the initiatives undertaken by manufacturers and organizations are as follows:

  • In March 2020, the Canadian Government committed USD 205.5 million for coronavirus research, boosting global funds. This investment is for research on medical counter-measures against COVID-19.
  • As part of a global effort to respond to the COVID-19 pandemic, European governments have pledged over USD 7.67 billion (EUR 7 billion) in initial funding.
  • The European Institute of Innovation & Technology (EIT) Health announced USD 7.69 million (EUR 7 million) in the fight against COVID-19, dedicated to 15 health innovation projects across Europe.

Key Findings of the Research antibodies and reagents market Study:

The Antibodies Segment to Dominate the Market in 2020

In 2020, based on product, the antibodies segment is projected to command the largest share of the overall research antibodies and reagents market. This can be attributed to the widespread application of antibodies in medicine and biomedical research to diagnose, drug development, and disease treatment. Further, the increasing proteomics & genomics-based research, funding for R&D, and rising need for disease-specific biomarkers is expanding the use of research antibodies in the future.

The Flow Cytometry Segment to Dominate the Market in 2020

In 2020, the flow cytometry segment is poised to command the largest share of the research antibodies and reagents market. The increasing focus on biomedical research for initiating developments in diagnosis and therapy, rising funding for biomarker discovery, and rising demand for antibody & cell-based research are the factors driving the growth of this segment.

The Proteomics segment to Dominate the Market 2020

In 2020, the proteomics segment is poised to command the largest share of the research antibodies and reagents market. The rising uptake of research antibodies in the significantly growing proteomics market, the upsurge in proteomic research, rising demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomic research are the factors driving the growth of this segment.

The Pharmaceutical and Biotechnology Industry to Dominate the Market in 2020

In 2020, the pharmaceutical and biotechnology industry is poised to command the largest share of the research antibodies and reagents market. The rising adoption of research antibodies & regents in the proteomics research and drug discovery & development with the rising focus of industry vendors on innovating therapeutics of chronic diseases is driving the growth of this segment.

Asia-Pacific: Fastest Growing Market

Asia-Pacific is expected to grow at the fastest growth rate of the research antibodies and reagents market. The factors driving the growth of the Asia-Pacific market include the demographic transition from high fertility & mortality to low fertility & mortality, accelerated growth of economies, lower regulatory hurdles, improving healthcare infrastructure, rising accessibility to healthcare services & innovative products, and continuous investment & focus of pharmaceuticals giants on this region.

Key Players

The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in the industry over the past four years (2016-2019). The key players profiled in the research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.) among others.

Scope of the Report:

Research Antibodies And Reagents Market, by Product Type

  • Antibodies
    • Antibodies Market, by Type
      • Primary Antibody
      • Secondary Antibody
    • Antibodies Market, by Production Type
      • Monoclonal Antibody
      • Polyclonal Antibody
      • Antibody Fragments
    • Antibodies Market, by Source
      • Mouse
      • Rabbit
      • Others
    • Antibodies Market, by Research Area
      • Oncology
      • Infectious Diseases
      • Cardiovascular Disease
      • Immunology
      • Neurology
      • Stem Cell Research
      • Others
  • Reagents
    • Sample Preparation Reagents
      • Media and Serum
      • Stain and Dyes
      • Probes
      • Buffers
      • Solvents
    • Antibody Production Reagents
      • Enzymes
      • Proteins
    • Other Research Reagents

Research Antibodies And Reagents Market, by Technology

  • Flow Cytometry
  • Immunofluorescence
  • Enzyme-Linked Immunosorbent Assay
  • Multiplex Immunosorbent Assay
  • Western Blot
  • Immunohistochemistry
  • Immunoprecipitation (IP)
  • Others

 Research Antibodies And Reagents Market, by Application

  • Proteomics
  • Drug Discovery and Development
  • Genomics

 Research Antibodies And Reagents Market, by End User

  • Pharmaceutical and Biotechnology Industry
  • Academic and Research Institutes
  • Contract Research Organizations

Research Antibodies And Reagents Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

What is the focus of the global research antibodies and reagents market?

The global research antibodies and reagents market covers the market size & forecasts the various research antibodies and reagents product used in the healthcare sector. The research antibodies and reagents market studied in this report involves the value analysis of various segments and subsegments of research antibodies and reagents at the regional and country levels.

What is the value of revenue generated from the sale of the research antibodies and reagents products across the globe? At what rate is their demand expected to grow in the next 5-7 years?

The global research antibodies and reagents market is projected to reach $6.32 billion by 2027, at a CAGR of 5.6% during the forecast period.

Which product type is estimated to hold the major share of the market?

In 2020, based on product, the antibodies segment is expected command the largest share of the overall market. However, the reagents segment is expected to grow with the fastest CAGR during the forecast period.

Which end-user segment is projected to create more traction in the global research antibodies and reagents market?

The contract research organizations segment is projected to register the fastest CAGR during the forecast period owing to increasing investment in assay development & drug discovery, and rising adoption of research antibodies and reagents in phases of drugs discovery and its pre-clinical studies.

What are the key factors supporting the growth of this market? What are the major opportunities for existing market players and new entrants in the global research antibodies and reagents market?

The increasing proteomics and genomics research studies increase in the funding for research activities, and growing industry-academia collaborations are the key factors supporting the growth of this market. Also, increasing investment in stem cell research, rising demand for protein therapeutics & personalized medicine, rising need for biomarker identification, and emerging economies represent high-growth opportunities for players in the future.

Who are the major players operating in the global research antibodies and reagents market?

The key players operating in the global research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA (Germany) Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.) among others.

Which regions/countries are expected to offer significant growth opportunities for the vendors operating in the global research antibodies and reagents market?

The emerging economies like China, India, Brazil etc. are projected to offer significant growth opportunities for the vendors in this market with demographic transition from high fertility & mortality to low fertility & mortality in the region; accelerated growth of economies; lower regulatory hurdles; improving healthcare infrastructure; rising accessibility to healthcare services & innovative products, growing income level of middle-class population; and continuous investment & focus of pharmaceuticals giants on this region.

1. Introduction
    1.1. Market Ecosystem
           1.1.1. Research Antibodies and Reagents Market
           1.1.2. Research Antibodies and Reagents Market, by Product
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research

3. Executive Summary

4. Market insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Rising Proteomics and Genomics Research Studies
                     4.2.1.2. Increase in the Funding for Research Activities
                     4.2.1.3. Growing Industry-Academia Collaboration
           4.2.2. Restraint
                     4.2.2.1. High Cost and Time Related to Identification and Development of Potential Antibodies
           4.2.3. Opportunities
                     4.2.3.1. Rising Demand for Protein Therapeutics and Personalized Medicines
                     4.2.3.2. Rising Investment and Focus on Stem-Cell Research
                     4.2.3.3. Rising Need for New Biomarker Identification
                     4.2.3.4. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
           4.2.4. Challenges
                     4.2.4.1. Issues Related to Quality and Stability of Research Antibodies
                     4.2.4.2. Intense Pricing Pressure on Leading Players

5. Research Antibodies and Reagents Market, by Product
    5.1. Introduction
    5.2. Antibodies
           5.2.1. Antibodies Market, by Type
                     5.2.1.1. Primary Antibodies
                     5.2.1.2. Secondary Antibody
           5.2.2. Antibodies Market, by Production Type
                     5.2.2.1. Monoclonal Antibody
                     5.2.2.2. Polyclonal Antibody
                     5.2.2.3. Antibody Fragments
           5.2.3. Antibody Market, by Source
                     5.2.3.1. Mouse
                     5.2.3.2. Rabbit
                     5.2.3.3. Other Sources
           5.2.4. Antibodies Market, by Research Area
                     5.2.4.1. Oncology
                     5.2.4.2. Infectious Diseases
                     5.2.4.3. Cardiovascular Disease
                     5.2.4.4. Immunology
                     5.2.4.5. Neurology
                     5.2.4.6. Stem Cell Research
                     5.2.4.7. Other Research Areas
    5.3. Reagents
           5.3.1. Sample Preparation Reagents
                     5.3.1.1. Media and Serum
                     5.3.1.2. Stains and Dyes
                     5.3.1.3. Probes
                     5.3.1.4. Buffers
                     5.3.1.5. Solvents
           5.3.2. Antibody Production Reagents
                     5.3.2.1. Enzymes
                     5.3.2.2. Proteins
           5.3.3. Other Research Reagents

6. Research Antibodies and Reagents Market, by Technology
    6.1. Introduction
    6.2. Flow Cytometry
    6.3. Immunofluorescence
    6.4. Enzyme-Linked Immunosorbent Assay
    6.5. Immunoprecipitation (IP)
    6.6. Multiplex Immunosorbent Assay
    6.7. Immunohistochemistry
    6.8. Western Blot
    6.9. Other Technologies

7. Research Antibodies and Reagents Market, by Application
    7.1. Introduction
    7.2. Proteomics
    7.3. Drug Discovery and Development
    7.4. Genomics

8. Research Antibodies and Reagents Market, by End User
    8.1. Introduction
    8.2. Pharmaceutical and Biotechnology Industry
    8.3. Academic and Research Institutes
    8.4. Contract Research Organizations

9. Research Antibodies and Reagents Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. France
           9.3.3. U.K.
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia-Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia-Pacific
    9.5. Latin America
    9.6. Middle East & Africa

10. Competitive Landscape
      10.1. Introduction
      10.2. Key Growth Strategies
      10.3. Competitive Benchmarking
      10.4. Market Share Analysis

11. Company Profiles
      11.1. GE Healthcare
               11.1.1. Business Overview
               11.1.2. Financial Overview
               11.1.3. Product Portfolio
      11.2. Merck KGaA
               11.2.1. Business Overview
               11.2.2. Financial Overview
               11.2.3. Product Portfolio
               11.2.4. Strategic Developments
      11.3. Thermo Fisher Scientific Inc.
               11.3.1. Business Overview
               11.3.2. Financial Overview
               11.3.3. Product Portfolio
               11.3.4. Strategic Developments
      11.4. F. Hoffmann-La Roche Ltd
               11.4.1. Business Overview
               11.4.2. Financial Overview
               11.4.3. Product Portfolio
      11.5. Rockland Immunochemicals Inc.
               11.5.1. Business Overview
               11.5.2. Product Portfolio
      11.6. Johnson & Johnson (J&J)
               11.6.1. Business Overview
               11.6.2. Financial Overview
               11.6.3. Product Portfolio
      11.7. Eli Lilly and Company
               11.7.1. Business Overview
               11.7.2. Financial Overview
               11.7.3. Product Portfolio
      11.8. Teva Pharmaceutical industries Limited
               11.8.1. Business Overview
               11.8.2. Financial Overview
               11.8.3. Product Portfolio
               11.8.4. Strategic Developments
      11.9. Abcam Plc
               11.9.1. Business Overview
               11.9.2. Financial Overview
               11.9.3. Product Portfolio
               11.9.4. Strategic Developments
      11.10. Agilent Technologies, Inc.
                 11.10.1. Business Overview
                 11.10.2. Financial Overview
                 11.10.3. Product Portfolio
      11.11. Cell Signaling Technology, Inc.
                 11.11.1. Business Overview
                 11.11.2. Product Portfolio
                 11.11.3. Strategic Developments
      11.12. Becton Dickinson and Company
                 11.12.1. Business Overview
                 11.12.2. Financial Overview
                 11.12.3. Product Portfolio
      11.13. Danaher Corporation
                 11.13.1. Business Overview
                 11.13.2. Financial Overview
                 11.13.3. Product Portfolio
      11.14. Lonza
                 11.14.1. Business Overview
                 11.14.2. Financial Overview
                 11.14.3. Product Portfolio
                 11.14.4. Strategic Development
      11.15. PerkinElmer, Inc.
                 11.15.1. Business Overview
                 11.15.2. Financial Overview
                 11.15.3. Product Portfolio
                 11.15.4. Strategic Developments
      11.16. GenScript Biotech Corporation
                 11.16.1. Business Overview
                 11.16.2. Financial Overview
                 11.16.3. Product Portfolio
                 11.16.4. Strategic Developments
      11.17. Bio-Techne Corporation
                 11.17.1. Business Overview
                 11.17.2. Financial Overview
                 11.17.3. Product Portfolio
                 11.17.4. Strategic Developments
      11.18. Bio-Rad Laboratories, Inc.
                 11.18.1. Business Overview
                 11.18.2. Financial Overview
                 11.18.3. Product Portfolio
                 11.18.4. Strategic Developments
      11.19. Santa Cruz Biotechnology, Inc.
                 11.19.1. Business Overview
                 11.19.2. Product Portfolio
      11.20. Biolegend, Inc.
                 11.20.1. Business Overview
                 11.20.2. Product Portfolio
                 11.20.3. Strategic Developments

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Global Research Antibodies and Reagents Market Drivers: Impact Analysis (2019-2025)
Table 2 Global Research Antibodies and Reagents Market Restraint: Impact Analysis (2019-2025)
Table 3 Global Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 4 Global Research Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 5 Global Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 6 Global Primary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 7 Global Secondary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 8 Global Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 9 Global Monoclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 10  Global Polyclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 11 Global Antibody Fragments Market Size, by Country/Region, 2018-2027 ($Million)
Table 12 Global Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 13 Global Mouse Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 14 Global Rabbit Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 15 Global Other Sources Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 16 Global Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 17 Global Research Antibodies Market Size for Oncology, by Country/Region, 2018-2027 ($Million)
Table 18 Global Research Antibodies Market Size for Infectious Diseases, by Country/Region, 2018-2027 ($Million)
Table 19 Global Research Antibodies Market Size for Cardiovascular Diseases, by Country/Region, 2018-2027 ($Million) 
Table 20 Global Research Antibodies Market Size for Immunology, by Country/Region, 2018-2027 ($Million)
Table 21 Global Research Antibodies Market Size for Neurology, by Country/Region, 2018-2027 ($Million)
Table 22 Global Research Antibodies Market Size for Stem Cell Research, by Country/Region, 2018-2027 ($Million)
Table 23 Global Research Antibodies Market Size for Other Research Areas, by Country/Region, 2018-2027 ($Million)
Table 24 Global Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 25 Global Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 26 Global Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 27 Global Sample Preparation Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 28 Global Media and Serum Market Size, by Country/Region, 2018-2027 ($Million)
Table 29 Global Stains and Dyes Market Size, by Country/Region, 2018-2027 ($Million)
Table 30 Global Probes Market Size, by Country/Region, 2018-2027 ($Million)
Table 31 Global Buffers Market Size, by Country/Region, 2018-2027 ($Million)
Table 32 Global Solvents Market Size, by Country/Region, 2018-2027 ($Million)
Table 33 Global Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 34 Global Antibody Production Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 35 Global Enzymes Market Size, by Country/Region, 2018-2027 ($Million)
Table 36 Global Proteins Market Size, by Country/Region, 2018-2027 ($Million)
Table 37 Global Other Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 38 Global Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 39 Global Research Antibodies and Reagents Market Size for Flow Cytometry, by Country/Region, 2018-2027 ($Million)
Table 40 Global Research Antibodies and Reagents Market Size for Immunofluorescence, by Country/Region, 2018-2027 ($Million)
Table 41 Global Research Antibodies and Reagents Market Size for Enzyme-Linked Immunosorbent Assay, by Country/Region, 2018-2027 ($Million)
Table 42 Global Research Antibodies and Reagents Market Size for Immunoprecipitation, by Country/Region, 2018-2027 ($Million)
Table 43 Global Multiplex Immunosorbent Assay Market Size, by Country/Region, 2018-2027 ($Million)
Table 44 Global Research Antibodies and Reagents Market Size for Immunohistochemistry, by Country/Region, 2018-2027 ($Million)
Table 45 Global Research Antibodies and Reagents Market Size for Western Blot, by Country/Region, 2018-2027 ($Million)
Table 46 Global Research Antibodies and Reagents Market Size for Other Technologies, by Country/Region, 2018-2027 ($Million)
Table 47 Global Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 48 Global Research Antibodies and Reagents Market Size for Proteomics, by Country/Region, 2018-2027 ($Million)
Table 49 Global Research Antibodies and Reagents Market Size for Drug Discovery and Development, by Country/Region, 2018-2027 ($Million)
Table 50 Global Research Antibodies and Reagents Market Size for Genomics, by Country/Region, 2018-2027 ($Million)
Table 51 Global Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 52 Global Research Antibodies and Reagents Market Size for Pharmaceutical and Biotechnology Industry, by Country/Region, 2018-2027 ($Million)
Table 53 Global Research Antibodies and Reagents Market Size for Academic and Research Institutes, by Country/Region, 2018-2027 ($Million)
Table 54 Global Research Antibodies and Reagents Market Size for Contract Research Organizations, by Country/Region, 2018-2027 ($Million)
Table 55 Global Research Antibodies and Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 56 North America: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 57 North America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 58 North America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 59 North America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 60 North America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 61 North America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 62 North America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 63 North America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 64 North America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 65 North America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 66 North America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 67 North America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 68 U.S.: Key Macroindicators
Table 69 U.S.: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 70 U.S.: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 71 U.S.: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 72 U.S.: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 73 U.S.: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 74 U.S.: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 75 U.S.: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 76 U.S.: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 77 U.S.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 78 U.S.: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 79 U.S.: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 80 Canada: Key Macroindicators
Table 81 Canada: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 82 Canada: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 83 Canada: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 84 Canada: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 85 Canada: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 86 Canada: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 87 Canada: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 88 Canada: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 89 Canada: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 90 Canada: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 91 Canada: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 92 Europe: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 93 Europe: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 94 Europe: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 95 Europe: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 96 Europe: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 97 Europe: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 98 Europe: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 99 Europe: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 100 Europe: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 101 Europe: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 102 Europe: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 103 Europe: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 104 Germany: Key Macroindicators
Table 105 Germany: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 106 Germany: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 107 Germany: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 108 Germany: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 109 Germany: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 110 Germany: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 111 Germany: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 112 Germany: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 113 Germany: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 114 Germany: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 115 Germany: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 116 France: Key Macroindicators
Table 117 France: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 118 France: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 119 France: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 120 France: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 121 France: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 122 France: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 123 France: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 124 France: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 125 France: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 126 France: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 127 France: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 128 U.K.: Key Macroindicators
Table 129 U.K.: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 130 U.K.: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 131 U.K.: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 132 U.K.: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 133 U.K.: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 134 U.K.: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 135 U.K.: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 136 U.K.: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 137 U.K.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 138 U.K.: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 139 U.K.: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 140 Italy: Key Macroindicators
Table 141 Italy: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 142 Italy: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 143 Italy: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 144 Italy: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 145 Italy: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 146 Italy: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 147 Italy: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 148 Italy: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 149 Italy: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 150 Italy: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 151 Italy: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 152 Spain: Key Macroindicators
Table 153 Spain: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 154 Spain: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 155 Spain: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 156 Spain: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 157 Spain: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 158 Spain: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 159 Spain: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 160 Spain: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 161 Spain: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 162 Spain: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 163 Spain: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 164 RoE: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 165 RoE: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 166 RoE: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 167 RoE: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 168 RoE: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 169 RoE: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 170 RoE: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 171 RoE: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 172 RoE: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 173 RoE: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 174 RoE: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 175 Asia Pacific: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 176 Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 177 Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 178 Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 179 Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 180 Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 181 Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 182 Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 183 Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 184 Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 185 Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 186 Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 187 Japan: Key Macroindicators
Table 188 Japan: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 189 Japan: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 190 Japan: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 191 Japan: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 192 Japan: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 193 Japan: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 194 Japan: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 195 Japan: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 196 Japan: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 197 Japan: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 198 Japan: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 199 China: Key Macroindicators
Table 200 China: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 201 China: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 202 China: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 203 China: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 204 China: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 205 China: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 206 China: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 207 China: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 208 China: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 209 China: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 210 China: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 211 India: Key Macroindicators
Table 212 India: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 213 India: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 214 India: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 215 India: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 216 India: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 217 India: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 218 India: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 219 India: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 220 India: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 221 India: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 222 India: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 223 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 224 Rest of Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 225 Rest of Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 226 Rest of Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 227 Rest of Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 228 Rest of Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 229 Rest of Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 230 Rest of Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 231 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 232 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 233 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 234 Latin America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 235 Latin America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 236 Latin America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 237 Latin America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 238 Latin America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 239 Latin America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 240 Latin America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 241 Latin America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 242 Latin America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 243 Latin America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 244 Latin America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 245 Middle East & Africa: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 246 Middle East & Africa: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 247 Middle East & Africa: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 248 Middle East & Africa: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 249 Middle East & Africa: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 250 Middle East & Africa: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 251 Middle East & Africa: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 252 Middle East & Africa: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 253 Middle East & Africa: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 254 Middle East & Africa: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 255 Middle East & Africa: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 256 Number of Developments by the Major Players during 2016-2019

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Reagents Dominate the Global Research Antibodies and Reagents Market
Figure 6 Global Research Antibodies and Reagents Market, by Technology, 2020-2027 ($Million)
Figure 7 Global Research Antibodies and Reagents Market, by Application, 2020-2027 ($Million)
Figure 8 Pharmaceutical and Biotechnology Industry Segment Is Expected to Be a Prominent End User for Research Antibodies and Reagents Market 
Figure 9 Research Antibodies and Reagents Market, by Region
Figure 10 Rate of Publication Related to Genomics, Proteomics or Metabolomics (2008-2016) 
Figure 11 Share of Medical and Health R&D Expenditure of U.S. by Type of organization: 2017 
Figure 12 Number of Therapeutic Proteins Approved Globally, 2012-2015 
Figure 13 NIH Spending on Stem Cell Research in the U.S. (2013-2016) 
Figure 14 Number of New Cancer Cases, Globally: 2012-2040 
Figure 15 Proportion of Population Aged 60 or Over in Asia, by Region, 2016-2050 
Figure 16 Monoclonal Antibody Approval Rate (2008-2015) 
Figure 17 Global Research Antibodies and Reagents Market Size, by Product, 2020-2027 ($Million)
Figure 18 Number of Cancer Cases and Deaths, Globally: 2018-2040
Figure 19 Global Number of People Living with HIV in 2017 (In Millions)
Figure 20 Number of Deaths Attributed to Cardiovascular Disease Globally, 2013-2030 (In Millions)
Figure 21 Global Research Antibodies and Reagents Market Size, by Technology, 2020-2027 ($Million)
Figure 22 Global Research Antibodies and Reagents Market Size, by Application, 2020-2027 ($Million)
Figure 23 Number of Biologics Approved by the U.S. FDA: 2010-2018
Figure 24 Global Research Antibodies and Reagents Market Size, by End User, 2020-2027 ($Million) 
Figure 25 Global Research Antibodies and Reagents Market Size, by Geography, 2020-2027 ($Million) 
Figure 26 Number of Geriatric Population (65 Years & Above) in the U.S., 2010-2060 (Millions) 
Figure 27 North America: Research Antibodies and Reagents Market Snapshot 
Figure 28 Number of People with Chronic Diseases in America.: 2005-2030 (Million) 
Figure 29 Pharma Member Company R&D Expenditure in the U.S., 2011-2017 ($Billion) 
Figure 30 Cancer Cases in Canada: 2018-2040 
Figure 31 Population Aged 60 or Over in Europe: 2017 and 2050 
Figure 32 Health Spending ($/Capita), by Eu5 Countries- 2018 
Figure 33 Europe: Research Antibodies and Reagents Market Size, by Country, 2020-2027 ($Million) 
Figure 34 Biotechnology Firms in Germany: 2010-2017 
Figure 35 Share of Population Aged 65 & Above In Total Population in France: 2010-2018 
Figure 36 Number of New Cancer Cases and Mortality in the U.K.: 2018-2040 
Figure 37 Number of Biotech Firms in Italy: 2008-2017 
Figure 38 Cancer Incidence by Country: 2018-2040 (Number of Cases) 
Figure 39 Asia-Pacific: Research Antibodies and Reagents Market Snapshot 
Figure 40 Population Aged 60 or Over in Japan (As % of Total Population):  2000-2030 
Figure 41 Cancer Incidence in Latin America & Caribbean, 2018-2040 (Number of Cases) 
Figure 42 Cancer Incidence in the Middle East and Africa: 2012 and 2030 
Figure 43 Key Growth Strategies Adopted by Leading Players, 2016-2019 
Figure 44 Research Antibodies and Reagents Market: Competitive Benchmarking 
Figure 45 Global Research Antibodies Market Share, by Key Player, 2018 
Figure 46 GE Healthcare: Financial Overview (2016-2018) 
Figure 47 Merck & Co., Inc.: Financial Overview (2016-2018) 
Figure 48 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018) 
Figure 49 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018) 
Figure 50 Johnson & Johnson: Financial Overview (2016-2018) 
Figure 51 Eli Lilly and Company: Financial Overview (2016-2018) 
Figure 52 Teva Pharmaceuticals Industries Limited: Financial Overview (2016-2018) 
Figure 53 Abcam Plc: Financial Overview (2017-2019) 
Figure 54 Agilent Technologies, Inc.: Financial Overview (2016-2018) 
Figure 55 Becton, Dickinson and Company: Financial Overview (2016-2018) 
Figure 56 Danaher Corporation: Financial Overview (2016-2018) 
Figure 57 Lonza: Financial Overview (2016-2018) 
Figure 58 PerkinElmer, Inc.: Financial Overview (2016-2018) 
Figure 59 GenScript Biotech Corporation: Financial Overview (2016-2018) 
Figure 60 Bio-Techne Corporation: Financial Overview (2017-2019) 
Figure 61 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)

 
Name can only consist of alphabets.
Please provide your full name.
 
Please provide valid email address.
Please provide your email address.
 
Please provide your job title.
 
Please provide your company name.
 
Please provide your company name.
 
Please provide valid phone number.
Please provide your phone number.
 
Please enter minimum 10 characters.
 
Please enter Captcha.
Please enter valid Captcha.

This website is secure and we do not share your personal information with any third party. Privacy Policy

Related Research

The research antibodies and reagents market is expected to grow at a CAGR of 5.6% from 2020 to 2027 to reach USD 6.32 billion by 2027. The main route of causing various chronic diseases is the presence of specific proteins, namely antigens, on the surface of pathogenic organisms. The immune system plays an important role in fighting against these antigens by producing three protein types-complement protein, antibodies, and interferons. Antibodies are formed by plasma or B or T cells in the body.

Moreover, they have high specificity, strong affinity, and long-term memory against specific pathogens. Thus, these antibodies are used for various applications. The factors such as increasing proteomics and genomics research studies, increased funding for research activities, and growing industry-academia collaborations drive the growth of this market.

However, high cost and time related to identifying and developing potential antibodies are expected to restrict this market's growth to a certain extent.

Research Antibodies and Reagents Market

                                                        Click here to: Get Free Sample Pages of this Report

Impact of COVID-19 on Research Antibodies and Reagents Market

The increasing cases of COVID-19 have led to a robust increase in research-based activities to develop effective diagnosis or therapy. The growing number of research activities is driving the adoption of research antibodies and reagents by various end-users. Some of the initiatives undertaken by manufacturers and organizations are as follows:

  • In March 2020, the Canadian Government committed USD 205.5 million for coronavirus research, boosting global funds. This investment is for research on medical counter-measures against COVID-19.
  • As part of a global effort to respond to the COVID-19 pandemic, European governments have pledged over USD 7.67 billion (EUR 7 billion) in initial funding.
  • The European Institute of Innovation & Technology (EIT) Health announced USD 7.69 million (EUR 7 million) in the fight against COVID-19, dedicated to 15 health innovation projects across Europe.

Key Findings of the Research antibodies and reagents market Study:

The Antibodies Segment to Dominate the Market in 2020

In 2020, based on product, the antibodies segment is projected to command the largest share of the overall research antibodies and reagents market. This can be attributed to the widespread application of antibodies in medicine and biomedical research to diagnose, drug development, and disease treatment. Further, the increasing proteomics & genomics-based research, funding for R&D, and rising need for disease-specific biomarkers is expanding the use of research antibodies in the future.

The Flow Cytometry Segment to Dominate the Market in 2020

In 2020, the flow cytometry segment is poised to command the largest share of the research antibodies and reagents market. The increasing focus on biomedical research for initiating developments in diagnosis and therapy, rising funding for biomarker discovery, and rising demand for antibody & cell-based research are the factors driving the growth of this segment.

The Proteomics segment to Dominate the Market 2020

In 2020, the proteomics segment is poised to command the largest share of the research antibodies and reagents market. The rising uptake of research antibodies in the significantly growing proteomics market, the upsurge in proteomic research, rising demand for personalized & protein therapeutics, and increasing public & private sector spending on proteomic research are the factors driving the growth of this segment.

The Pharmaceutical and Biotechnology Industry to Dominate the Market in 2020

In 2020, the pharmaceutical and biotechnology industry is poised to command the largest share of the research antibodies and reagents market. The rising adoption of research antibodies & regents in the proteomics research and drug discovery & development with the rising focus of industry vendors on innovating therapeutics of chronic diseases is driving the growth of this segment.

Asia-Pacific: Fastest Growing Market

Asia-Pacific is expected to grow at the fastest growth rate of the research antibodies and reagents market. The factors driving the growth of the Asia-Pacific market include the demographic transition from high fertility & mortality to low fertility & mortality, accelerated growth of economies, lower regulatory hurdles, improving healthcare infrastructure, rising accessibility to healthcare services & innovative products, and continuous investment & focus of pharmaceuticals giants on this region.

Key Players

The report includes a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in the industry over the past four years (2016-2019). The key players profiled in the research antibodies and reagents market are GE Healthcare (U.S.), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Rockland Immunochemicals Inc. (U.S.), Johnson & Johnson (U.S.), Agilent Technologies, Inc. (U.S.), Eli Lily and Company (U.S.), Becton Dickinson and Company (U.S.), Danaher Corporation (U.S.), PerkinElmer, Inc. (U.S.), GenScript Biotech Corporation (U.S.), Lonza (Switzerland), Bio-Techne Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Teva Pharmaceutical Industries Limited (Israel), Santa Cruz Biotechnology, Inc. (U.S.), and BioLegend, Inc. (U.S.) among others.

Scope of the Report:

Research Antibodies And Reagents Market, by Product Type

  • Antibodies
    • Antibodies Market, by Type
      • Primary Antibody
      • Secondary Antibody
    • Antibodies Market, by Production Type
      • Monoclonal Antibody
      • Polyclonal Antibody
      • Antibody Fragments
    • Antibodies Market, by Source
      • Mouse
      • Rabbit
      • Others
    • Antibodies Market, by Research Area
      • Oncology
      • Infectious Diseases
      • Cardiovascular Disease
      • Immunology
      • Neurology
      • Stem Cell Research
      • Others
  • Reagents
    • Sample Preparation Reagents
      • Media and Serum
      • Stain and Dyes
      • Probes
      • Buffers
      • Solvents
    • Antibody Production Reagents
      • Enzymes
      • Proteins
    • Other Research Reagents

Research Antibodies And Reagents Market, by Technology

  • Flow Cytometry
  • Immunofluorescence
  • Enzyme-Linked Immunosorbent Assay
  • Multiplex Immunosorbent Assay
  • Western Blot
  • Immunohistochemistry
  • Immunoprecipitation (IP)
  • Others

 Research Antibodies And Reagents Market, by Application

  • Proteomics
  • Drug Discovery and Development
  • Genomics

 Research Antibodies And Reagents Market, by End User

  • Pharmaceutical and Biotechnology Industry
  • Academic and Research Institutes
  • Contract Research Organizations

Research Antibodies And Reagents Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East & Africa

Key questions answered in the report:

  Request Sample

1. Introduction
    1.1. Market Ecosystem
           1.1.1. Research Antibodies and Reagents Market
           1.1.2. Research Antibodies and Reagents Market, by Product
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research

3. Executive Summary

4. Market insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Rising Proteomics and Genomics Research Studies
                     4.2.1.2. Increase in the Funding for Research Activities
                     4.2.1.3. Growing Industry-Academia Collaboration
           4.2.2. Restraint
                     4.2.2.1. High Cost and Time Related to Identification and Development of Potential Antibodies
           4.2.3. Opportunities
                     4.2.3.1. Rising Demand for Protein Therapeutics and Personalized Medicines
                     4.2.3.2. Rising Investment and Focus on Stem-Cell Research
                     4.2.3.3. Rising Need for New Biomarker Identification
                     4.2.3.4. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
           4.2.4. Challenges
                     4.2.4.1. Issues Related to Quality and Stability of Research Antibodies
                     4.2.4.2. Intense Pricing Pressure on Leading Players

5. Research Antibodies and Reagents Market, by Product
    5.1. Introduction
    5.2. Antibodies
           5.2.1. Antibodies Market, by Type
                     5.2.1.1. Primary Antibodies
                     5.2.1.2. Secondary Antibody
           5.2.2. Antibodies Market, by Production Type
                     5.2.2.1. Monoclonal Antibody
                     5.2.2.2. Polyclonal Antibody
                     5.2.2.3. Antibody Fragments
           5.2.3. Antibody Market, by Source
                     5.2.3.1. Mouse
                     5.2.3.2. Rabbit
                     5.2.3.3. Other Sources
           5.2.4. Antibodies Market, by Research Area
                     5.2.4.1. Oncology
                     5.2.4.2. Infectious Diseases
                     5.2.4.3. Cardiovascular Disease
                     5.2.4.4. Immunology
                     5.2.4.5. Neurology
                     5.2.4.6. Stem Cell Research
                     5.2.4.7. Other Research Areas
    5.3. Reagents
           5.3.1. Sample Preparation Reagents
                     5.3.1.1. Media and Serum
                     5.3.1.2. Stains and Dyes
                     5.3.1.3. Probes
                     5.3.1.4. Buffers
                     5.3.1.5. Solvents
           5.3.2. Antibody Production Reagents
                     5.3.2.1. Enzymes
                     5.3.2.2. Proteins
           5.3.3. Other Research Reagents

6. Research Antibodies and Reagents Market, by Technology
    6.1. Introduction
    6.2. Flow Cytometry
    6.3. Immunofluorescence
    6.4. Enzyme-Linked Immunosorbent Assay
    6.5. Immunoprecipitation (IP)
    6.6. Multiplex Immunosorbent Assay
    6.7. Immunohistochemistry
    6.8. Western Blot
    6.9. Other Technologies

7. Research Antibodies and Reagents Market, by Application
    7.1. Introduction
    7.2. Proteomics
    7.3. Drug Discovery and Development
    7.4. Genomics

8. Research Antibodies and Reagents Market, by End User
    8.1. Introduction
    8.2. Pharmaceutical and Biotechnology Industry
    8.3. Academic and Research Institutes
    8.4. Contract Research Organizations

9. Research Antibodies and Reagents Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. France
           9.3.3. U.K.
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia-Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia-Pacific
    9.5. Latin America
    9.6. Middle East & Africa

10. Competitive Landscape
      10.1. Introduction
      10.2. Key Growth Strategies
      10.3. Competitive Benchmarking
      10.4. Market Share Analysis

11. Company Profiles
      11.1. GE Healthcare
               11.1.1. Business Overview
               11.1.2. Financial Overview
               11.1.3. Product Portfolio
      11.2. Merck KGaA
               11.2.1. Business Overview
               11.2.2. Financial Overview
               11.2.3. Product Portfolio
               11.2.4. Strategic Developments
      11.3. Thermo Fisher Scientific Inc.
               11.3.1. Business Overview
               11.3.2. Financial Overview
               11.3.3. Product Portfolio
               11.3.4. Strategic Developments
      11.4. F. Hoffmann-La Roche Ltd
               11.4.1. Business Overview
               11.4.2. Financial Overview
               11.4.3. Product Portfolio
      11.5. Rockland Immunochemicals Inc.
               11.5.1. Business Overview
               11.5.2. Product Portfolio
      11.6. Johnson & Johnson (J&J)
               11.6.1. Business Overview
               11.6.2. Financial Overview
               11.6.3. Product Portfolio
      11.7. Eli Lilly and Company
               11.7.1. Business Overview
               11.7.2. Financial Overview
               11.7.3. Product Portfolio
      11.8. Teva Pharmaceutical industries Limited
               11.8.1. Business Overview
               11.8.2. Financial Overview
               11.8.3. Product Portfolio
               11.8.4. Strategic Developments
      11.9. Abcam Plc
               11.9.1. Business Overview
               11.9.2. Financial Overview
               11.9.3. Product Portfolio
               11.9.4. Strategic Developments
      11.10. Agilent Technologies, Inc.
                 11.10.1. Business Overview
                 11.10.2. Financial Overview
                 11.10.3. Product Portfolio
      11.11. Cell Signaling Technology, Inc.
                 11.11.1. Business Overview
                 11.11.2. Product Portfolio
                 11.11.3. Strategic Developments
      11.12. Becton Dickinson and Company
                 11.12.1. Business Overview
                 11.12.2. Financial Overview
                 11.12.3. Product Portfolio
      11.13. Danaher Corporation
                 11.13.1. Business Overview
                 11.13.2. Financial Overview
                 11.13.3. Product Portfolio
      11.14. Lonza
                 11.14.1. Business Overview
                 11.14.2. Financial Overview
                 11.14.3. Product Portfolio
                 11.14.4. Strategic Development
      11.15. PerkinElmer, Inc.
                 11.15.1. Business Overview
                 11.15.2. Financial Overview
                 11.15.3. Product Portfolio
                 11.15.4. Strategic Developments
      11.16. GenScript Biotech Corporation
                 11.16.1. Business Overview
                 11.16.2. Financial Overview
                 11.16.3. Product Portfolio
                 11.16.4. Strategic Developments
      11.17. Bio-Techne Corporation
                 11.17.1. Business Overview
                 11.17.2. Financial Overview
                 11.17.3. Product Portfolio
                 11.17.4. Strategic Developments
      11.18. Bio-Rad Laboratories, Inc.
                 11.18.1. Business Overview
                 11.18.2. Financial Overview
                 11.18.3. Product Portfolio
                 11.18.4. Strategic Developments
      11.19. Santa Cruz Biotechnology, Inc.
                 11.19.1. Business Overview
                 11.19.2. Product Portfolio
      11.20. Biolegend, Inc.
                 11.20.1. Business Overview
                 11.20.2. Product Portfolio
                 11.20.3. Strategic Developments

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Global Research Antibodies and Reagents Market Drivers: Impact Analysis (2019-2025)
Table 2 Global Research Antibodies and Reagents Market Restraint: Impact Analysis (2019-2025)
Table 3 Global Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 4 Global Research Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 5 Global Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 6 Global Primary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 7 Global Secondary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 8 Global Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 9 Global Monoclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 10  Global Polyclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 11 Global Antibody Fragments Market Size, by Country/Region, 2018-2027 ($Million)
Table 12 Global Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 13 Global Mouse Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 14 Global Rabbit Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 15 Global Other Sources Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 16 Global Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 17 Global Research Antibodies Market Size for Oncology, by Country/Region, 2018-2027 ($Million)
Table 18 Global Research Antibodies Market Size for Infectious Diseases, by Country/Region, 2018-2027 ($Million)
Table 19 Global Research Antibodies Market Size for Cardiovascular Diseases, by Country/Region, 2018-2027 ($Million) 
Table 20 Global Research Antibodies Market Size for Immunology, by Country/Region, 2018-2027 ($Million)
Table 21 Global Research Antibodies Market Size for Neurology, by Country/Region, 2018-2027 ($Million)
Table 22 Global Research Antibodies Market Size for Stem Cell Research, by Country/Region, 2018-2027 ($Million)
Table 23 Global Research Antibodies Market Size for Other Research Areas, by Country/Region, 2018-2027 ($Million)
Table 24 Global Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 25 Global Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 26 Global Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 27 Global Sample Preparation Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 28 Global Media and Serum Market Size, by Country/Region, 2018-2027 ($Million)
Table 29 Global Stains and Dyes Market Size, by Country/Region, 2018-2027 ($Million)
Table 30 Global Probes Market Size, by Country/Region, 2018-2027 ($Million)
Table 31 Global Buffers Market Size, by Country/Region, 2018-2027 ($Million)
Table 32 Global Solvents Market Size, by Country/Region, 2018-2027 ($Million)
Table 33 Global Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 34 Global Antibody Production Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 35 Global Enzymes Market Size, by Country/Region, 2018-2027 ($Million)
Table 36 Global Proteins Market Size, by Country/Region, 2018-2027 ($Million)
Table 37 Global Other Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 38 Global Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 39 Global Research Antibodies and Reagents Market Size for Flow Cytometry, by Country/Region, 2018-2027 ($Million)
Table 40 Global Research Antibodies and Reagents Market Size for Immunofluorescence, by Country/Region, 2018-2027 ($Million)
Table 41 Global Research Antibodies and Reagents Market Size for Enzyme-Linked Immunosorbent Assay, by Country/Region, 2018-2027 ($Million)
Table 42 Global Research Antibodies and Reagents Market Size for Immunoprecipitation, by Country/Region, 2018-2027 ($Million)
Table 43 Global Multiplex Immunosorbent Assay Market Size, by Country/Region, 2018-2027 ($Million)
Table 44 Global Research Antibodies and Reagents Market Size for Immunohistochemistry, by Country/Region, 2018-2027 ($Million)
Table 45 Global Research Antibodies and Reagents Market Size for Western Blot, by Country/Region, 2018-2027 ($Million)
Table 46 Global Research Antibodies and Reagents Market Size for Other Technologies, by Country/Region, 2018-2027 ($Million)
Table 47 Global Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 48 Global Research Antibodies and Reagents Market Size for Proteomics, by Country/Region, 2018-2027 ($Million)
Table 49 Global Research Antibodies and Reagents Market Size for Drug Discovery and Development, by Country/Region, 2018-2027 ($Million)
Table 50 Global Research Antibodies and Reagents Market Size for Genomics, by Country/Region, 2018-2027 ($Million)
Table 51 Global Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 52 Global Research Antibodies and Reagents Market Size for Pharmaceutical and Biotechnology Industry, by Country/Region, 2018-2027 ($Million)
Table 53 Global Research Antibodies and Reagents Market Size for Academic and Research Institutes, by Country/Region, 2018-2027 ($Million)
Table 54 Global Research Antibodies and Reagents Market Size for Contract Research Organizations, by Country/Region, 2018-2027 ($Million)
Table 55 Global Research Antibodies and Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 56 North America: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 57 North America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 58 North America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 59 North America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 60 North America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 61 North America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 62 North America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 63 North America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 64 North America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 65 North America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 66 North America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 67 North America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 68 U.S.: Key Macroindicators
Table 69 U.S.: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 70 U.S.: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 71 U.S.: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 72 U.S.: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 73 U.S.: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 74 U.S.: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 75 U.S.: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 76 U.S.: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 77 U.S.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 78 U.S.: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 79 U.S.: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 80 Canada: Key Macroindicators
Table 81 Canada: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 82 Canada: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 83 Canada: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 84 Canada: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 85 Canada: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 86 Canada: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 87 Canada: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 88 Canada: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 89 Canada: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 90 Canada: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 91 Canada: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 92 Europe: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 93 Europe: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 94 Europe: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 95 Europe: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 96 Europe: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 97 Europe: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 98 Europe: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 99 Europe: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 100 Europe: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 101 Europe: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 102 Europe: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 103 Europe: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 104 Germany: Key Macroindicators
Table 105 Germany: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 106 Germany: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 107 Germany: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 108 Germany: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 109 Germany: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 110 Germany: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 111 Germany: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 112 Germany: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 113 Germany: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 114 Germany: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 115 Germany: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 116 France: Key Macroindicators
Table 117 France: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 118 France: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 119 France: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 120 France: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 121 France: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 122 France: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 123 France: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 124 France: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 125 France: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 126 France: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 127 France: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 128 U.K.: Key Macroindicators
Table 129 U.K.: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 130 U.K.: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 131 U.K.: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 132 U.K.: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 133 U.K.: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 134 U.K.: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 135 U.K.: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 136 U.K.: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 137 U.K.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 138 U.K.: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 139 U.K.: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 140 Italy: Key Macroindicators
Table 141 Italy: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 142 Italy: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 143 Italy: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 144 Italy: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 145 Italy: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 146 Italy: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 147 Italy: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 148 Italy: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 149 Italy: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 150 Italy: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 151 Italy: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 152 Spain: Key Macroindicators
Table 153 Spain: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 154 Spain: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 155 Spain: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 156 Spain: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 157 Spain: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 158 Spain: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 159 Spain: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 160 Spain: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 161 Spain: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 162 Spain: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 163 Spain: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 164 RoE: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 165 RoE: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 166 RoE: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 167 RoE: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 168 RoE: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 169 RoE: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 170 RoE: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 171 RoE: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 172 RoE: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 173 RoE: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 174 RoE: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 175 Asia Pacific: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 176 Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 177 Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 178 Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 179 Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 180 Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 181 Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 182 Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 183 Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 184 Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 185 Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 186 Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 187 Japan: Key Macroindicators
Table 188 Japan: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 189 Japan: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 190 Japan: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 191 Japan: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 192 Japan: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 193 Japan: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 194 Japan: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 195 Japan: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 196 Japan: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 197 Japan: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 198 Japan: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 199 China: Key Macroindicators
Table 200 China: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 201 China: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 202 China: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 203 China: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 204 China: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 205 China: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 206 China: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 207 China: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 208 China: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 209 China: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 210 China: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 211 India: Key Macroindicators
Table 212 India: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 213 India: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 214 India: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 215 India: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 216 India: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 217 India: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 218 India: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 219 India: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 220 India: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 221 India: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 222 India: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 223 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 224 Rest of Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 225 Rest of Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 226 Rest of Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 227 Rest of Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 228 Rest of Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 229 Rest of Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 230 Rest of Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 231 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 232 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 233 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 234 Latin America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 235 Latin America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 236 Latin America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 237 Latin America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 238 Latin America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 239 Latin America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 240 Latin America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 241 Latin America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 242 Latin America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 243 Latin America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 244 Latin America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 245 Middle East & Africa: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 246 Middle East & Africa: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 247 Middle East & Africa: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 248 Middle East & Africa: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 249 Middle East & Africa: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 250 Middle East & Africa: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 251 Middle East & Africa: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 252 Middle East & Africa: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 253 Middle East & Africa: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 254 Middle East & Africa: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 255 Middle East & Africa: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 256 Number of Developments by the Major Players during 2016-2019

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Reagents Dominate the Global Research Antibodies and Reagents Market
Figure 6 Global Research Antibodies and Reagents Market, by Technology, 2020-2027 ($Million)
Figure 7 Global Research Antibodies and Reagents Market, by Application, 2020-2027 ($Million)
Figure 8 Pharmaceutical and Biotechnology Industry Segment Is Expected to Be a Prominent End User for Research Antibodies and Reagents Market 
Figure 9 Research Antibodies and Reagents Market, by Region
Figure 10 Rate of Publication Related to Genomics, Proteomics or Metabolomics (2008-2016) 
Figure 11 Share of Medical and Health R&D Expenditure of U.S. by Type of organization: 2017 
Figure 12 Number of Therapeutic Proteins Approved Globally, 2012-2015 
Figure 13 NIH Spending on Stem Cell Research in the U.S. (2013-2016) 
Figure 14 Number of New Cancer Cases, Globally: 2012-2040 
Figure 15 Proportion of Population Aged 60 or Over in Asia, by Region, 2016-2050 
Figure 16 Monoclonal Antibody Approval Rate (2008-2015) 
Figure 17 Global Research Antibodies and Reagents Market Size, by Product, 2020-2027 ($Million)
Figure 18 Number of Cancer Cases and Deaths, Globally: 2018-2040
Figure 19 Global Number of People Living with HIV in 2017 (In Millions)
Figure 20 Number of Deaths Attributed to Cardiovascular Disease Globally, 2013-2030 (In Millions)
Figure 21 Global Research Antibodies and Reagents Market Size, by Technology, 2020-2027 ($Million)
Figure 22 Global Research Antibodies and Reagents Market Size, by Application, 2020-2027 ($Million)
Figure 23 Number of Biologics Approved by the U.S. FDA: 2010-2018
Figure 24 Global Research Antibodies and Reagents Market Size, by End User, 2020-2027 ($Million) 
Figure 25 Global Research Antibodies and Reagents Market Size, by Geography, 2020-2027 ($Million) 
Figure 26 Number of Geriatric Population (65 Years & Above) in the U.S., 2010-2060 (Millions) 
Figure 27 North America: Research Antibodies and Reagents Market Snapshot 
Figure 28 Number of People with Chronic Diseases in America.: 2005-2030 (Million) 
Figure 29 Pharma Member Company R&D Expenditure in the U.S., 2011-2017 ($Billion) 
Figure 30 Cancer Cases in Canada: 2018-2040 
Figure 31 Population Aged 60 or Over in Europe: 2017 and 2050 
Figure 32 Health Spending ($/Capita), by Eu5 Countries- 2018 
Figure 33 Europe: Research Antibodies and Reagents Market Size, by Country, 2020-2027 ($Million) 
Figure 34 Biotechnology Firms in Germany: 2010-2017 
Figure 35 Share of Population Aged 65 & Above In Total Population in France: 2010-2018 
Figure 36 Number of New Cancer Cases and Mortality in the U.K.: 2018-2040 
Figure 37 Number of Biotech Firms in Italy: 2008-2017 
Figure 38 Cancer Incidence by Country: 2018-2040 (Number of Cases) 
Figure 39 Asia-Pacific: Research Antibodies and Reagents Market Snapshot 
Figure 40 Population Aged 60 or Over in Japan (As % of Total Population):  2000-2030 
Figure 41 Cancer Incidence in Latin America & Caribbean, 2018-2040 (Number of Cases) 
Figure 42 Cancer Incidence in the Middle East and Africa: 2012 and 2030 
Figure 43 Key Growth Strategies Adopted by Leading Players, 2016-2019 
Figure 44 Research Antibodies and Reagents Market: Competitive Benchmarking 
Figure 45 Global Research Antibodies Market Share, by Key Player, 2018 
Figure 46 GE Healthcare: Financial Overview (2016-2018) 
Figure 47 Merck & Co., Inc.: Financial Overview (2016-2018) 
Figure 48 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018) 
Figure 49 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018) 
Figure 50 Johnson & Johnson: Financial Overview (2016-2018) 
Figure 51 Eli Lilly and Company: Financial Overview (2016-2018) 
Figure 52 Teva Pharmaceuticals Industries Limited: Financial Overview (2016-2018) 
Figure 53 Abcam Plc: Financial Overview (2017-2019) 
Figure 54 Agilent Technologies, Inc.: Financial Overview (2016-2018) 
Figure 55 Becton, Dickinson and Company: Financial Overview (2016-2018) 
Figure 56 Danaher Corporation: Financial Overview (2016-2018) 
Figure 57 Lonza: Financial Overview (2016-2018) 
Figure 58 PerkinElmer, Inc.: Financial Overview (2016-2018) 
Figure 59 GenScript Biotech Corporation: Financial Overview (2016-2018) 
Figure 60 Bio-Techne Corporation: Financial Overview (2017-2019) 
Figure 61 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)

  Request Sample

1. Introduction
    1.1. Market Ecosystem
           1.1.1. Research Antibodies and Reagents Market
           1.1.2. Research Antibodies and Reagents Market, by Product
    1.2. Currency and Limitations
           1.2.1. Currency
           1.2.2. Limitations
    1.3. Key Stakeholders

2. Research Methodology
    2.1. Research Process
           2.1.1. Secondary Research
           2.1.2. Primary Research

3. Executive Summary

4. Market insights
    4.1. Introduction
    4.2. Market Dynamics
           4.2.1. Drivers
                     4.2.1.1. Rising Proteomics and Genomics Research Studies
                     4.2.1.2. Increase in the Funding for Research Activities
                     4.2.1.3. Growing Industry-Academia Collaboration
           4.2.2. Restraint
                     4.2.2.1. High Cost and Time Related to Identification and Development of Potential Antibodies
           4.2.3. Opportunities
                     4.2.3.1. Rising Demand for Protein Therapeutics and Personalized Medicines
                     4.2.3.2. Rising Investment and Focus on Stem-Cell Research
                     4.2.3.3. Rising Need for New Biomarker Identification
                     4.2.3.4. Significant Opportunities from Emerging Asia-Pacific and Latin-American Markets
           4.2.4. Challenges
                     4.2.4.1. Issues Related to Quality and Stability of Research Antibodies
                     4.2.4.2. Intense Pricing Pressure on Leading Players

5. Research Antibodies and Reagents Market, by Product
    5.1. Introduction
    5.2. Antibodies
           5.2.1. Antibodies Market, by Type
                     5.2.1.1. Primary Antibodies
                     5.2.1.2. Secondary Antibody
           5.2.2. Antibodies Market, by Production Type
                     5.2.2.1. Monoclonal Antibody
                     5.2.2.2. Polyclonal Antibody
                     5.2.2.3. Antibody Fragments
           5.2.3. Antibody Market, by Source
                     5.2.3.1. Mouse
                     5.2.3.2. Rabbit
                     5.2.3.3. Other Sources
           5.2.4. Antibodies Market, by Research Area
                     5.2.4.1. Oncology
                     5.2.4.2. Infectious Diseases
                     5.2.4.3. Cardiovascular Disease
                     5.2.4.4. Immunology
                     5.2.4.5. Neurology
                     5.2.4.6. Stem Cell Research
                     5.2.4.7. Other Research Areas
    5.3. Reagents
           5.3.1. Sample Preparation Reagents
                     5.3.1.1. Media and Serum
                     5.3.1.2. Stains and Dyes
                     5.3.1.3. Probes
                     5.3.1.4. Buffers
                     5.3.1.5. Solvents
           5.3.2. Antibody Production Reagents
                     5.3.2.1. Enzymes
                     5.3.2.2. Proteins
           5.3.3. Other Research Reagents

6. Research Antibodies and Reagents Market, by Technology
    6.1. Introduction
    6.2. Flow Cytometry
    6.3. Immunofluorescence
    6.4. Enzyme-Linked Immunosorbent Assay
    6.5. Immunoprecipitation (IP)
    6.6. Multiplex Immunosorbent Assay
    6.7. Immunohistochemistry
    6.8. Western Blot
    6.9. Other Technologies

7. Research Antibodies and Reagents Market, by Application
    7.1. Introduction
    7.2. Proteomics
    7.3. Drug Discovery and Development
    7.4. Genomics

8. Research Antibodies and Reagents Market, by End User
    8.1. Introduction
    8.2. Pharmaceutical and Biotechnology Industry
    8.3. Academic and Research Institutes
    8.4. Contract Research Organizations

9. Research Antibodies and Reagents Market, by Geography
    9.1. Introduction
    9.2. North America
           9.2.1. U.S.
           9.2.2. Canada
    9.3. Europe
           9.3.1. Germany
           9.3.2. France
           9.3.3. U.K.
           9.3.4. Italy
           9.3.5. Spain
           9.3.6. Rest of Europe
    9.4. Asia-Pacific
           9.4.1. Japan
           9.4.2. China
           9.4.3. India
           9.4.4. Rest of Asia-Pacific
    9.5. Latin America
    9.6. Middle East & Africa

10. Competitive Landscape
      10.1. Introduction
      10.2. Key Growth Strategies
      10.3. Competitive Benchmarking
      10.4. Market Share Analysis

11. Company Profiles
      11.1. GE Healthcare
               11.1.1. Business Overview
               11.1.2. Financial Overview
               11.1.3. Product Portfolio
      11.2. Merck KGaA
               11.2.1. Business Overview
               11.2.2. Financial Overview
               11.2.3. Product Portfolio
               11.2.4. Strategic Developments
      11.3. Thermo Fisher Scientific Inc.
               11.3.1. Business Overview
               11.3.2. Financial Overview
               11.3.3. Product Portfolio
               11.3.4. Strategic Developments
      11.4. F. Hoffmann-La Roche Ltd
               11.4.1. Business Overview
               11.4.2. Financial Overview
               11.4.3. Product Portfolio
      11.5. Rockland Immunochemicals Inc.
               11.5.1. Business Overview
               11.5.2. Product Portfolio
      11.6. Johnson & Johnson (J&J)
               11.6.1. Business Overview
               11.6.2. Financial Overview
               11.6.3. Product Portfolio
      11.7. Eli Lilly and Company
               11.7.1. Business Overview
               11.7.2. Financial Overview
               11.7.3. Product Portfolio
      11.8. Teva Pharmaceutical industries Limited
               11.8.1. Business Overview
               11.8.2. Financial Overview
               11.8.3. Product Portfolio
               11.8.4. Strategic Developments
      11.9. Abcam Plc
               11.9.1. Business Overview
               11.9.2. Financial Overview
               11.9.3. Product Portfolio
               11.9.4. Strategic Developments
      11.10. Agilent Technologies, Inc.
                 11.10.1. Business Overview
                 11.10.2. Financial Overview
                 11.10.3. Product Portfolio
      11.11. Cell Signaling Technology, Inc.
                 11.11.1. Business Overview
                 11.11.2. Product Portfolio
                 11.11.3. Strategic Developments
      11.12. Becton Dickinson and Company
                 11.12.1. Business Overview
                 11.12.2. Financial Overview
                 11.12.3. Product Portfolio
      11.13. Danaher Corporation
                 11.13.1. Business Overview
                 11.13.2. Financial Overview
                 11.13.3. Product Portfolio
      11.14. Lonza
                 11.14.1. Business Overview
                 11.14.2. Financial Overview
                 11.14.3. Product Portfolio
                 11.14.4. Strategic Development
      11.15. PerkinElmer, Inc.
                 11.15.1. Business Overview
                 11.15.2. Financial Overview
                 11.15.3. Product Portfolio
                 11.15.4. Strategic Developments
      11.16. GenScript Biotech Corporation
                 11.16.1. Business Overview
                 11.16.2. Financial Overview
                 11.16.3. Product Portfolio
                 11.16.4. Strategic Developments
      11.17. Bio-Techne Corporation
                 11.17.1. Business Overview
                 11.17.2. Financial Overview
                 11.17.3. Product Portfolio
                 11.17.4. Strategic Developments
      11.18. Bio-Rad Laboratories, Inc.
                 11.18.1. Business Overview
                 11.18.2. Financial Overview
                 11.18.3. Product Portfolio
                 11.18.4. Strategic Developments
      11.19. Santa Cruz Biotechnology, Inc.
                 11.19.1. Business Overview
                 11.19.2. Product Portfolio
      11.20. Biolegend, Inc.
                 11.20.1. Business Overview
                 11.20.2. Product Portfolio
                 11.20.3. Strategic Developments

12. Appendix
      12.1. Questionnaire
      12.2. Available Customization

List of Tables

Table 1 Global Research Antibodies and Reagents Market Drivers: Impact Analysis (2019-2025)
Table 2 Global Research Antibodies and Reagents Market Restraint: Impact Analysis (2019-2025)
Table 3 Global Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 4 Global Research Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 5 Global Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 6 Global Primary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 7 Global Secondary Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 8 Global Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 9 Global Monoclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 10  Global Polyclonal Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 11 Global Antibody Fragments Market Size, by Country/Region, 2018-2027 ($Million)
Table 12 Global Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 13 Global Mouse Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 14 Global Rabbit Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 15 Global Other Sources Derived Antibodies Market Size, by Country/Region, 2018-2027 ($Million)
Table 16 Global Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 17 Global Research Antibodies Market Size for Oncology, by Country/Region, 2018-2027 ($Million)
Table 18 Global Research Antibodies Market Size for Infectious Diseases, by Country/Region, 2018-2027 ($Million)
Table 19 Global Research Antibodies Market Size for Cardiovascular Diseases, by Country/Region, 2018-2027 ($Million) 
Table 20 Global Research Antibodies Market Size for Immunology, by Country/Region, 2018-2027 ($Million)
Table 21 Global Research Antibodies Market Size for Neurology, by Country/Region, 2018-2027 ($Million)
Table 22 Global Research Antibodies Market Size for Stem Cell Research, by Country/Region, 2018-2027 ($Million)
Table 23 Global Research Antibodies Market Size for Other Research Areas, by Country/Region, 2018-2027 ($Million)
Table 24 Global Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 25 Global Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 26 Global Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 27 Global Sample Preparation Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 28 Global Media and Serum Market Size, by Country/Region, 2018-2027 ($Million)
Table 29 Global Stains and Dyes Market Size, by Country/Region, 2018-2027 ($Million)
Table 30 Global Probes Market Size, by Country/Region, 2018-2027 ($Million)
Table 31 Global Buffers Market Size, by Country/Region, 2018-2027 ($Million)
Table 32 Global Solvents Market Size, by Country/Region, 2018-2027 ($Million)
Table 33 Global Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 34 Global Antibody Production Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 35 Global Enzymes Market Size, by Country/Region, 2018-2027 ($Million)
Table 36 Global Proteins Market Size, by Country/Region, 2018-2027 ($Million)
Table 37 Global Other Research Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 38 Global Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 39 Global Research Antibodies and Reagents Market Size for Flow Cytometry, by Country/Region, 2018-2027 ($Million)
Table 40 Global Research Antibodies and Reagents Market Size for Immunofluorescence, by Country/Region, 2018-2027 ($Million)
Table 41 Global Research Antibodies and Reagents Market Size for Enzyme-Linked Immunosorbent Assay, by Country/Region, 2018-2027 ($Million)
Table 42 Global Research Antibodies and Reagents Market Size for Immunoprecipitation, by Country/Region, 2018-2027 ($Million)
Table 43 Global Multiplex Immunosorbent Assay Market Size, by Country/Region, 2018-2027 ($Million)
Table 44 Global Research Antibodies and Reagents Market Size for Immunohistochemistry, by Country/Region, 2018-2027 ($Million)
Table 45 Global Research Antibodies and Reagents Market Size for Western Blot, by Country/Region, 2018-2027 ($Million)
Table 46 Global Research Antibodies and Reagents Market Size for Other Technologies, by Country/Region, 2018-2027 ($Million)
Table 47 Global Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 48 Global Research Antibodies and Reagents Market Size for Proteomics, by Country/Region, 2018-2027 ($Million)
Table 49 Global Research Antibodies and Reagents Market Size for Drug Discovery and Development, by Country/Region, 2018-2027 ($Million)
Table 50 Global Research Antibodies and Reagents Market Size for Genomics, by Country/Region, 2018-2027 ($Million)
Table 51 Global Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 52 Global Research Antibodies and Reagents Market Size for Pharmaceutical and Biotechnology Industry, by Country/Region, 2018-2027 ($Million)
Table 53 Global Research Antibodies and Reagents Market Size for Academic and Research Institutes, by Country/Region, 2018-2027 ($Million)
Table 54 Global Research Antibodies and Reagents Market Size for Contract Research Organizations, by Country/Region, 2018-2027 ($Million)
Table 55 Global Research Antibodies and Reagents Market Size, by Country/Region, 2018-2027 ($Million)
Table 56 North America: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 57 North America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 58 North America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 59 North America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 60 North America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 61 North America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 62 North America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 63 North America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 64 North America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 65 North America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 66 North America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 67 North America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 68 U.S.: Key Macroindicators
Table 69 U.S.: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 70 U.S.: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 71 U.S.: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 72 U.S.: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 73 U.S.: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 74 U.S.: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 75 U.S.: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 76 U.S.: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 77 U.S.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 78 U.S.: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 79 U.S.: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 80 Canada: Key Macroindicators
Table 81 Canada: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 82 Canada: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 83 Canada: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 84 Canada: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 85 Canada: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 86 Canada: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 87 Canada: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 88 Canada: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 89 Canada: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 90 Canada: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 91 Canada: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 92 Europe: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 93 Europe: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 94 Europe: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 95 Europe: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 96 Europe: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 97 Europe: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 98 Europe: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 99 Europe: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 100 Europe: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 101 Europe: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 102 Europe: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 103 Europe: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 104 Germany: Key Macroindicators
Table 105 Germany: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 106 Germany: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 107 Germany: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 108 Germany: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 109 Germany: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 110 Germany: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 111 Germany: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 112 Germany: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 113 Germany: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 114 Germany: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 115 Germany: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 116 France: Key Macroindicators
Table 117 France: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 118 France: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 119 France: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 120 France: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 121 France: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 122 France: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 123 France: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 124 France: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 125 France: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 126 France: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 127 France: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 128 U.K.: Key Macroindicators
Table 129 U.K.: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 130 U.K.: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 131 U.K.: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 132 U.K.: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 133 U.K.: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 134 U.K.: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 135 U.K.: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 136 U.K.: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 137 U.K.: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 138 U.K.: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 139 U.K.: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 140 Italy: Key Macroindicators
Table 141 Italy: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 142 Italy: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 143 Italy: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 144 Italy: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 145 Italy: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 146 Italy: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 147 Italy: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 148 Italy: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 149 Italy: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 150 Italy: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 151 Italy: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 152 Spain: Key Macroindicators
Table 153 Spain: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 154 Spain: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 155 Spain: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 156 Spain: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 157 Spain: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 158 Spain: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 159 Spain: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 160 Spain: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 161 Spain: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 162 Spain: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 163 Spain: Research Antibodies and Reagents Market Size, by End User, 2018-2027($Million)
Table 164 RoE: Research Antibodies and Reagents Market Size, by Product, 2018-2027($Million)
Table 165 RoE: Research Reagents Market Size, by Type, 2018-2027($Million)
Table 166 RoE: Sample Preparation Reagents Market Size, by Type, 2018-2027($Million)
Table 167 RoE: Antibody Production Reagents Market Size, by Type, 2018-2027($Million)
Table 168 RoE: Research Antibodies Market Size, by Type, 2018-2027($Million)
Table 169 RoE: Research Antibodies Market Size, by Production Type, 2018-2027($Million)
Table 170 RoE: Research Antibodies Market Size, by Source, 2018-2027($Million)
Table 171 RoE: Research Antibodies Market Size, by Research Area, 2018-2027($Million)
Table 172 RoE: Research Antibodies and Reagents Market Size, by Technology, 2018-2027($Million)
Table 173 RoE: Research Antibodies and Reagents Market Size, by Application, 2018-2027($Million)
Table 174 RoE: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 175 Asia Pacific: Research Antibodies and Reagents Market Size, by Country, 2018-2027 ($Million)
Table 176 Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 177 Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 178 Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 179 Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 180 Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 181 Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 182 Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 183 Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 184 Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 185 Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 186 Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 187 Japan: Key Macroindicators
Table 188 Japan: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 189 Japan: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 190 Japan: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 191 Japan: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 192 Japan: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 193 Japan: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 194 Japan: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 195 Japan: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 196 Japan: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 197 Japan: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 198 Japan: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 199 China: Key Macroindicators
Table 200 China: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 201 China: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 202 China: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 203 China: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 204 China: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 205 China: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 206 China: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 207 China: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 208 China: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 209 China: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 210 China: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 211 India: Key Macroindicators
Table 212 India: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 213 India: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 214 India: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 215 India: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 216 India: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 217 India: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 218 India: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 219 India: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 220 India: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 221 India: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 222 India: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 223 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 224 Rest of Asia-Pacific: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 225 Rest of Asia-Pacific: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 226 Rest of Asia-Pacific: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 227 Rest of Asia-Pacific: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 228 Rest of Asia-Pacific: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 229 Rest of Asia-Pacific: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 230 Rest of Asia-Pacific: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 231 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 232 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 233 Rest of Asia-Pacific: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 234 Latin America: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 235 Latin America: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 236 Latin America: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 237 Latin America: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 238 Latin America: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 239 Latin America: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 240 Latin America: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 241 Latin America: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 242 Latin America: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 243 Latin America: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 244 Latin America: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 245 Middle East & Africa: Research Antibodies and Reagents Market Size, by Product, 2018-2027 ($Million)
Table 246 Middle East & Africa: Research Antibodies Market Size, by Type, 2018-2027 ($Million)
Table 247 Middle East & Africa: Research Antibodies Market Size, by Production Type, 2018-2027 ($Million)
Table 248 Middle East & Africa: Research Antibodies Market Size, by Source, 2018-2027 ($Million)
Table 249 Middle East & Africa: Research Antibodies Market Size, by Research Area, 2018-2027 ($Million)
Table 250 Middle East & Africa: Research Reagents Market Size, by Type, 2018-2027 ($Million)
Table 251 Middle East & Africa: Sample Preparation Reagents Market Size, by Type, 2018-2027 ($Million)
Table 252 Middle East & Africa: Antibody Production Reagents Market Size, by Type, 2018-2027 ($Million)
Table 253 Middle East & Africa: Research Antibodies and Reagents Market Size, by Technology, 2018-2027 ($Million)
Table 254 Middle East & Africa: Research Antibodies and Reagents Market Size, by Application, 2018-2027 ($Million)
Table 255 Middle East & Africa: Research Antibodies and Reagents Market Size, by End User, 2018-2027 ($Million)
Table 256 Number of Developments by the Major Players during 2016-2019

List of Figures

Figure 1 Research Process
Figure 2 Key Executives Interviewed
Figure 3 Primary Research Techniques
Figure 4 Market Size Estimation
Figure 5 Reagents Dominate the Global Research Antibodies and Reagents Market
Figure 6 Global Research Antibodies and Reagents Market, by Technology, 2020-2027 ($Million)
Figure 7 Global Research Antibodies and Reagents Market, by Application, 2020-2027 ($Million)
Figure 8 Pharmaceutical and Biotechnology Industry Segment Is Expected to Be a Prominent End User for Research Antibodies and Reagents Market 
Figure 9 Research Antibodies and Reagents Market, by Region
Figure 10 Rate of Publication Related to Genomics, Proteomics or Metabolomics (2008-2016) 
Figure 11 Share of Medical and Health R&D Expenditure of U.S. by Type of organization: 2017 
Figure 12 Number of Therapeutic Proteins Approved Globally, 2012-2015 
Figure 13 NIH Spending on Stem Cell Research in the U.S. (2013-2016) 
Figure 14 Number of New Cancer Cases, Globally: 2012-2040 
Figure 15 Proportion of Population Aged 60 or Over in Asia, by Region, 2016-2050 
Figure 16 Monoclonal Antibody Approval Rate (2008-2015) 
Figure 17 Global Research Antibodies and Reagents Market Size, by Product, 2020-2027 ($Million)
Figure 18 Number of Cancer Cases and Deaths, Globally: 2018-2040
Figure 19 Global Number of People Living with HIV in 2017 (In Millions)
Figure 20 Number of Deaths Attributed to Cardiovascular Disease Globally, 2013-2030 (In Millions)
Figure 21 Global Research Antibodies and Reagents Market Size, by Technology, 2020-2027 ($Million)
Figure 22 Global Research Antibodies and Reagents Market Size, by Application, 2020-2027 ($Million)
Figure 23 Number of Biologics Approved by the U.S. FDA: 2010-2018
Figure 24 Global Research Antibodies and Reagents Market Size, by End User, 2020-2027 ($Million) 
Figure 25 Global Research Antibodies and Reagents Market Size, by Geography, 2020-2027 ($Million) 
Figure 26 Number of Geriatric Population (65 Years & Above) in the U.S., 2010-2060 (Millions) 
Figure 27 North America: Research Antibodies and Reagents Market Snapshot 
Figure 28 Number of People with Chronic Diseases in America.: 2005-2030 (Million) 
Figure 29 Pharma Member Company R&D Expenditure in the U.S., 2011-2017 ($Billion) 
Figure 30 Cancer Cases in Canada: 2018-2040 
Figure 31 Population Aged 60 or Over in Europe: 2017 and 2050 
Figure 32 Health Spending ($/Capita), by Eu5 Countries- 2018 
Figure 33 Europe: Research Antibodies and Reagents Market Size, by Country, 2020-2027 ($Million) 
Figure 34 Biotechnology Firms in Germany: 2010-2017 
Figure 35 Share of Population Aged 65 & Above In Total Population in France: 2010-2018 
Figure 36 Number of New Cancer Cases and Mortality in the U.K.: 2018-2040 
Figure 37 Number of Biotech Firms in Italy: 2008-2017 
Figure 38 Cancer Incidence by Country: 2018-2040 (Number of Cases) 
Figure 39 Asia-Pacific: Research Antibodies and Reagents Market Snapshot 
Figure 40 Population Aged 60 or Over in Japan (As % of Total Population):  2000-2030 
Figure 41 Cancer Incidence in Latin America & Caribbean, 2018-2040 (Number of Cases) 
Figure 42 Cancer Incidence in the Middle East and Africa: 2012 and 2030 
Figure 43 Key Growth Strategies Adopted by Leading Players, 2016-2019 
Figure 44 Research Antibodies and Reagents Market: Competitive Benchmarking 
Figure 45 Global Research Antibodies Market Share, by Key Player, 2018 
Figure 46 GE Healthcare: Financial Overview (2016-2018) 
Figure 47 Merck & Co., Inc.: Financial Overview (2016-2018) 
Figure 48 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018) 
Figure 49 F. Hoffmann-La Roche Ltd: Financial Overview (2016-2018) 
Figure 50 Johnson & Johnson: Financial Overview (2016-2018) 
Figure 51 Eli Lilly and Company: Financial Overview (2016-2018) 
Figure 52 Teva Pharmaceuticals Industries Limited: Financial Overview (2016-2018) 
Figure 53 Abcam Plc: Financial Overview (2017-2019) 
Figure 54 Agilent Technologies, Inc.: Financial Overview (2016-2018) 
Figure 55 Becton, Dickinson and Company: Financial Overview (2016-2018) 
Figure 56 Danaher Corporation: Financial Overview (2016-2018) 
Figure 57 Lonza: Financial Overview (2016-2018) 
Figure 58 PerkinElmer, Inc.: Financial Overview (2016-2018) 
Figure 59 GenScript Biotech Corporation: Financial Overview (2016-2018) 
Figure 60 Bio-Techne Corporation: Financial Overview (2017-2019) 
Figure 61 Bio-Rad Laboratories, Inc.: Financial Overview (2016-2018)

  Request Sample
Related Research